Document is current
Any future updates will be listed below
-
Authors
Munshi, Pashna N. https://orcid.org/0000-0002-8079-9443
Hamadani, Mehdi https://orcid.org/0000-0001-5372-510X
Kumar, Ambuj https://orcid.org/0000-0003-1260-6694
Dreger, Peter https://orcid.org/0000-0002-7429-8570
Friedberg, Jonathan W.
Dreyling, Martin
Kahl, Brad
Jerkeman, Mats https://orcid.org/0000-0003-4509-6707
Kharfan-Dabaja, Mohamed A. https://orcid.org/0000-0001-7394-5185
Locke, Frederick L. https://orcid.org/0000-0001-9063-6691
Shadman, Mazyar
Hill, Brian T.
Ahmed, Sairah https://orcid.org/0000-0001-7302-8299
Herrera, Alex F.
Sauter, Craig S.
Bachanova, Veronika https://orcid.org/0000-0002-9325-432X
Ghosh, Nilanjan
Lunning, Matthew
Kenkre, Vaishalee P.
Aljurf, Mahmoud
Wang, Michael https://orcid.org/0000-0001-9748-5486
Maddocks, Kami J.
Leonard, John P.
Kamdar, Manali
Phillips, Tycel
Cashen, Amanda F.
Inwards, David J.
Sureda, Anna
Cohen, Jonathon B.
Smith, Sonali M.
Carlo-Stella, Carmello https://orcid.org/0000-0003-3144-0124
Savani, Bipin
Robinson, Stephen P.
Fenske, Timothy S.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (U24CA076518)
- License Information
-
More Information
Article History
Received: 4 March 2021
Revised: 8 March 2021
Accepted: 25 March 2021
First Online: 20 August 2021
Compliance with ethical standards
:
: MH reports: Research Support/Funding: Takeda Pharmaceutical Company; Spectrum Pharmaceuticals; Astellas Pharma. Consultancy: Janssen; Incyte Corporation; ADC Therapeutics; Celgene Corporation; Omeros, Verastem, MorphoSys. Speaker’s Bureau: Sanofi Genzyme, AstraZeneca, BeiGene. TSF reports: Research Support/Funding: Novartis, Portola, Curis; Consultancy: Adaptive Biotechnologies, AbbVie, KaryoPharm, Kite, MorphoSys, Pharmacyclics, Sanofi. Speaker’s Bureau: Sanofi, Seattle Genetics, AstraZeneca, Celgene/ Bristol-Myers Squibb, Adaptive Biotechnologies. PNM reports: Speaker’s Bureau: Kite, a Gilead Company, Incyte. JBC reports: Consulting/Advisory Boards: Janssen, Adicet, BeiGene, Cellectar, Kite/Gilead, Adaptive, Aptitude Health, Astra Zeneca, Loxo. Research Support/Funding: Novartis, BMS/Celgene, Takeda, Genentech, Astra Zeneca, Loxo, LAM, Atara, BeiGene. NG reports: Speakers Bureau: Kite Pharma, Astra Zeneca, AbbVie, Janssen, BMS, Epizyme; Consulting/Advisory: Kite Pharma, Astra Zeneca, AbbVie, Janssen, BMS, Incyte, Epizyme, Karyopharma, Genmab, Adaptive Biotech, T.G. Therapeutics, ADC Therapeutics, BeiGene; Research funding: Genentech/Roche, BMS, T.G. Therapeutics, Pharmacyclics, Kite Pharma. MK reports: Research Support/Funding: TG Therapeutics, Genentech. Consultancy: AbbVie, KaryoPharm, Kite, AstraZeneca, Celgene/ Bristol-Myers Squibb, Adaptive Biotechnologies, Curio Science. Speaker’s bureau: SeaGen. MJ reports: Research Support/Funding: Janssen, Celgene, Abbvie, Gilead, Roche, Consultancy: Janssen; Incyte; Gilead, Roche, Bristol-Myers Squibb; Acerta; BioInvent. JWF reports: DSMB activities: Bayer, Ascerta, Novartis. CCS reports: Research support/Funding: ADC Therapeutics, Sanofi, Roche. Consulting/Advisory: Sanofi, ADC Therapeutics, Roche, Karyopharm Therapeutics, Celgene/Bristol-Myers Squibb, Incyte. Honoraria: Bristol-Myers Squibb, Janssen Oncology, AstraZeneca. Travel Grants: Roche, Janssen, Takeda, ADC Therapeutics. VB reports: Advisory Board: Kite, Gamida Cell: Research support/Funding: Incyte, Gamida Cell, GT Biopharma. TP reports: Research Support/Funding: Incyte, BMS/Celgene, Bayer, Abbvie, Genentech; Consultancy: BMS, Bayer, Abbvie, Genentech, Gilead, Gilead/Kite TG Therapeutics, ADC Therapeutics, Incyte, MrophoSys, BeiGene, AstraZenca, Epizyme. FLL reports: Research Support/Funding: Kite, a Gilead Company; Scientific Advisor: Allogene, Amgen, Bluebird Bio, BMS/Celgene, Calibr, Celgene, GammaDelta Therapeutics, Iovance, Kite/Gilead, Legend Biotech, Novartis, Wugen; Consultancy: Cellular Biomedicine Group, Cowen Consulting, Gerson Lehrman Group (GLG), EcoR1, Emerging Therapies. BK reports: Research Support/Funding: Abbvie, Acerta, AstraZeneca, Beigene, Celgene, Genentech; Consulting: Abbvie, Acerta, AstraZeneca, Beigene, Celgene, Kite, Genentech, Pharmacyclics, Janssen. MAKD reports: Consultancy: Pharmacyclics, Daiichi Sankyo. AFH reports: Consulting or Advisory Role: Bristol-Myers Squibb, Merck, Seattle Genetics, Karyopharm, Genentech/Roche; Research Funding: Bristol-Myers Squibb (Inst), Genentech/Roche (Inst), Merck (Inst), Seattle Genetics (Inst), ADC Therapeutics (Inst), Gilead/Kite Pharma (Inst); Travel, Accommodations, Expenses: Bristol-Myers Squibb. KJM reports: Research funding: Pharmacyclics, BMS, Merck, Novartis; Consultancy: Pharmacyclics, Janssen, Morphosys, Celgene, Beigene, Kite, Karyopharm, ADC Therapeutics, Seattle Genetics. VPK reports: Research funding: Novartis. DJI reports: Research funding: Acerta Pharma. CSS reports: Consultancy/Advisory boards: Juno Therapeutics, Sanofi-Genzyme, Spectrum Pharmaceuticals, Novartis, Genmab, Precision Biosciences, Kite/a Gilead Company, Celgene/BMS, Gamida Cell, Karyopharm Therapeutics, GSK; Research Funding: Juno Therapeutics, Celgene/BMS, Bristol-Myers Squibb, Precision Biosciences and Sanofi-Genzyme. PD reports: consultancy for AbbVie, AstraZeneca, bluebird bio, Gilead, Janssen, Novartis, Riemser, Roche; speakers bureau for AbbVie, AstraZeneca, Gilead, Novartis, Riemser, Roche; research support from Riemser. JPL reports: Research support: Leukemia & Lymphoma Society, Genentech Foundation. Consulting: Sutro, Miltenyi, AstraZeneca, Epizyme, BMS/Celgene, Regeneron, Bayer, Gilead/Kite, Karyopharm, GenMab, Genentech/Roche, Abbvie, Incyte. MD reports: institutional research funding: Abbvie, Bayer, Celgene, Janssen, Roche. Advisory Boards: Astra Zeneca, Bayer, Beigene, Celgene, Genmab, Gilead, Incyte, Janssen, Novartis, Roche. Speaker’s honoraria: Amgen, Astra Zeneca, Bayer, Celgene, Gilead, Janssen, Roche. BTH reports: research funding: Kite/Gilead, Celgene/BMS, Genentech, Pharmacyclics, Abbvie. Consulting: Kite/Gilead, Celgene/BMS, Novartis, Beigene, AstraZeneca, Genentech, Abbvie.
